Original Research

Published on 17 Nov 2023

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

in Vaccines and Molecular Therapeutics

Lorenzo Federico
Brandon Malone
Simen Tennøe
Viktoriia Chaban
Julie Røkke Osen
Murat Gainullin
Eva Smorodina
Hassen Kared
Rahmad Akbar
Victor Greiff

Frontiers in Immunology

doi 10.3389/fimmu.2023.1265044

3,423 views
4 citations

Original Research

Published on 16 Nov 2023

Evaluation of three formulations based on Polymorphic membrane protein D in mice infected with Chlamydia trachomatis

in Vaccines and Molecular Therapeutics

Romina Cecilia Russi
Diego del Balzo
Ivana Gabriela Reidel
Mariano Alonso Bivou
Noelia Flor
Agustín Lujan
Diego Sanchez
María Teresa Damiani
Carolina Veaute

Frontiers in Immunology

doi 10.3389/fimmu.2023.1267684

1,364 views

Clinical Trial

Published on 15 Nov 2023

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV

in Vaccines and Molecular Therapeutics

Zhengchao Lv
Songqin Lv
Qin Li
Yafei Xia
Zaineng Feng
Haohong Zhang
Haihao Yang
Zhao Wu
Nanting Zou
Qingyan Mo

Frontiers in Immunology

doi 10.3389/fimmu.2023.1264160

1,877 views
3 citations

Original Research

Published on 15 Nov 2023

Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches

in Vaccines and Molecular Therapeutics

Jyotisha
Rahila Qureshi
Insaf Ahmed Qureshi

Frontiers in Immunology

doi 10.3389/fimmu.2023.1269774

3,553 views
5 citations

Original Research

Published on 15 Nov 2023

The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying 99mTc and a near-infrared fluorescent dye for intra-operative decision-making

in Vaccines and Molecular Therapeutics

Noemi B. Declerck
Celine Huygen
Lukasz Mateusiak
Marcus C. M. Stroet
Sophie Hernot

Frontiers in Immunology

doi 10.3389/fimmu.2023.1285923

1,889 views
1 citation

Case Report

Published on 14 Nov 2023

Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response

in Vaccines and Molecular Therapeutics

Thomas Menter
Carl P. Zinner
Christoph T. Berger
Philip Went
Alexandar Tzankov

Frontiers in Immunology

doi 10.3389/fimmu.2023.1285168

1,490 views

Original Research

Published on 10 Nov 2023

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron

in Vaccines and Molecular Therapeutics

Daniela Bottero
Erika Rudi
Pablo Martin Aispuro
Eugenia Zurita
Emilia Gaillard
Maria M. Gonzalez Lopez Ledesma
Juan Malito
Matthew Stuible
Nicolas Ambrosis
Yves Durocher

Frontiers in Immunology

doi 10.3389/fimmu.2023.1271209

1,806 views

Correction

Published on 09 Nov 2023

Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

in Vaccines and Molecular Therapeutics

Catarina E. Hioe
Xiaomei Liu
Andrew N. Banin
Daniel W. Heindel
Je´romine Klingler
Priyanka G. Rao
Christina C. Luo
Xunqing Jiang
Shilpi Pandey
Tracy Ordonez

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329069

770 views

Original Research

Published on 08 Nov 2023

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

in Vaccines and Molecular Therapeutics

Filipe Colaco Mariz
Kerstin Putzker
Peter Sehr
Martin Müller

Frontiers in Immunology

doi 10.3389/fimmu.2023.1272018

1,523 views
1 citation

Perspective

Published on 08 Nov 2023

From rejection to the Nobel Prize: Karikó and Weissman’s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology

in Vaccines and Molecular Therapeutics

Amit Bansal

Frontiers in Immunology

doi 10.3389/fimmu.2023.1306025

5,447 views
3 citations

Original Research

Published on 07 Nov 2023

A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses

in Vaccines and Molecular Therapeutics

Xueting Fan
Xiuqin Zhao
Ruibai Wang
Machao Li
Xiuli Luan
Ruihuan Wang
Kanglin Wan
Haican Liu

Frontiers in Immunology

doi 10.3389/fimmu.2023.1276887

1,613 views
1 citation

Review

Published on 03 Nov 2023

Side effects of COVID-19 vaccines in the middle eastern population

in Vaccines and Molecular Therapeutics

Ghida M. Murished
Iman Dandachi
Waleed Aljabr

Frontiers in Immunology

doi 10.3389/fimmu.2023.1270187

5,702 views

Original Research

Published on 02 Nov 2023

A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation

in Vaccines and Molecular Therapeutics

Fan Jiang
Yong Han
Yinping Liu
Yong Xue
Peng Cheng
Li Xiao
Wenping Gong

Frontiers in Immunology

doi 10.3389/fimmu.2023.1280299

6,931 views
8 citations

Review

Published on 02 Nov 2023

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates

in Vaccines and Molecular Therapeutics

Fangbin Zhou
Dongmei Zhang

Frontiers in Immunology

doi 10.3389/fimmu.2023.1238649

5,667 views
9 citations

Original Research

Published on 02 Nov 2023

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC

in Vaccines and Molecular Therapeutics

Geertje J. Dreyer
Jos JM. Drabbels
Johan W. de Fijter
Cees van Kooten
Marlies EJ. Reinders
Sebastiaan Heidt

Frontiers in Immunology

doi 10.3389/fimmu.2023.1240347

1,441 views
2 citations

Original Research

Published on 02 Nov 2023

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals

in Vaccines and Molecular Therapeutics

Zoltán Szekanecz
Zoltán Vokó
Orsolya Surján
Éva Rákóczi
Szilvia Szamosi
Gabriella Szűcs
Éva Szekanecz
Cecília Müller
Zoltán Kiss

Frontiers in Immunology

doi 10.3389/fimmu.2023.1247129

1,343 views
4 citations

Navigation group

Articles

Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence

Evaluation of three formulations based on Polymorphic membrane protein D in mice infected with Chlamydia trachomatis

A third (booster) dose of the inactivated SARS-CoV-2 vaccine elicits immunogenicity and T follicular helper cell responses in people living with HIV

Development of a multi-epitope vaccine candidate for leishmanial parasites applying immunoinformatics and in vitro approaches

The GEM-handle as convenient labeling strategy for bimodal single-domain antibody-based tracers carrying 99mTc and a near-infrared fluorescent dye for intra-operative decision-making

Case Report: Gene expression profiling of COVID-19 vaccination-related lymphadenopathies reveals evidence of a dominantly extrafollicular immune response

Heterologous booster with a novel formulation containing glycosylated trimeric S protein is effective against Omicron

Corrigendum: Vaccination with immune complexes modulates the elicitation of functional antibodies against HIV-1

Advances on two serological assays for human papillomavirus provide insights on the reactivity of antibodies against a cross-neutralization epitope of the minor capsid protein L2

From rejection to the Nobel Prize: Karikó and Weissman’s pioneering work on mRNA vaccines, and the need for diversity and inclusion in translational immunology

A novel multistage antigens ERA005f confer protection against Mycobacterium tuberculosis by driving Th-1 and Th-17 type T cell immune responses

Side effects of COVID-19 vaccines in the middle eastern population

A comprehensive approach to developing a multi-epitope vaccine against Mycobacterium tuberculosis: from in silico design to in vitro immunization evaluation

Recent advance in the development of tuberculosis vaccines in clinical trials and virus-like particle-based vaccine candidates

Cell-free DNA measurement of three genomes after allogeneic MSC therapy in kidney transplant recipients indicates early cell death of infused MSC

Effectiveness and waning of protection with the BNT162b2 vaccine against the SARS-CoV-2 Delta variant in immunocompromised individuals